Globus Medical EBITDA 2010-2024 | GMED

Globus Medical annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Globus Medical EBITDA for the quarter ending September 30, 2024 was $0.182B, a 221.04% increase year-over-year.
  • Globus Medical EBITDA for the twelve months ending September 30, 2024 was $0.622B, a 115.63% increase year-over-year.
  • Globus Medical 2023 annual EBITDA was $0.359B, a 18.87% increase from 2022.
  • Globus Medical 2022 annual EBITDA was $0.302B, a 23.3% increase from 2021.
  • Globus Medical 2021 annual EBITDA was $0.245B, a 39.86% increase from 2020.
Globus Medical Annual EBITDA
(Millions of US $)
2023 $359
2022 $302
2021 $245
2020 $175
2019 $224
2018 $213
2017 $207
2016 $200
2015 $200
2014 $163
2013 $123
2012 $133
2011 $114
2010 $103
2009 $95
Globus Medical Quarterly EBITDA
(Millions of US $)
2024-09-30 $182
2024-06-30 $174
2024-03-31 $124
2023-12-31 $142
2023-09-30 $57
2023-06-30 $85
2023-03-31 $75
2022-12-31 $72
2022-09-30 $79
2022-06-30 $86
2022-03-31 $65
2021-12-31 $36
2021-09-30 $71
2021-06-30 $66
2021-03-31 $72
2020-12-31 $76
2020-09-30 $66
2020-06-30 $-10
2020-03-31 $43
2019-12-31 $64
2019-09-30 $55
2019-06-30 $55
2019-03-31 $49
2018-12-31 $55
2018-09-30 $49
2018-06-30 $53
2018-03-31 $56
2017-12-31 $58
2017-09-30 $47
2017-06-30 $49
2017-03-31 $54
2016-12-31 $57
2016-09-30 $46
2016-06-30 $46
2016-03-31 $50
2015-12-31 $63
2015-09-30 $48
2015-06-30 $44
2015-03-31 $45
2014-12-31 $46
2014-09-30 $41
2014-06-30 $38
2014-03-31 $38
2013-12-31 $38
2013-09-30 $35
2013-06-30 $17
2013-03-31 $34
2012-12-31 $34
2012-09-30 $32
2012-06-30 $35
2012-03-31 $32
2011-12-31 $28
2011-09-30 $31
2011-06-30 $28
2011-03-31 $27
2010-12-31
2009-12-31
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $11.294B $1.568B
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $204.393B 24.93
Intuitive Surgical (ISRG) United States $193.619B 101.23
Edwards Lifesciences (EW) United States $43.533B 27.64
Alcon (ALC) Switzerland $42.700B 28.57
IQVIA Holdings (IQV) United States $36.494B 20.11
IDEXX Laboratories (IDXX) United States $35.790B 42.15
DexCom (DXCM) United States $31.431B 47.33
Waters (WAT) United States $22.876B 33.83
STERIS (STE) Ireland $20.691B 23.82
SONOVA HOLDING (SONVY) Switzerland $19.760B 0.00
Hologic (HOLX) United States $17.141B 18.51
Fresenius Medical Care AG KGaA (FMS) Germany $14.008B 14.38
Sysmex ADR (SSMXY) Japan $12.776B 40.07
Penumbra (PEN) United States $9.735B 95.36
Masimo (MASI) United States $9.336B 45.18
Teleflex (TFX) United States $8.528B 13.60
Glaukos (GKOS) United States $7.879B 0.00
PROCEPT BioRobotics (PRCT) United States $4.728B 0.00
Integer Holdings (ITGR) United States $4.717B 26.73
Inari Medical (NARI) United States $3.408B 0.00
Veracyte (VCYT) United States $3.372B 101.19
LivaNova (LIVN) United Kingdom $2.796B 16.14
Nihon Kohden (NHNKY) Japan $2.337B 17.75
Tandem Diabetes Care (TNDM) United States $2.267B 0.00
TransMedics (TMDX) United States $2.261B 71.66
Elekta AB (EKTAY) Sweden $2.229B 20.04
Integra LifeSciences Holdings (IART) United States $1.864B 9.74
RxSight (RXST) United States $1.515B 0.00
Alphatec Holdings (ATEC) United States $1.374B 0.00
Artivion (AORT) United States $1.254B 83.11
OPKO Health (OPK) United States $1.085B 0.00
Pulse Biosciences (PLSE) United States $1.062B 0.00
Paragon 28 (FNA) United States $0.874B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.859B 14.60
ORTHOFIX MEDICAL INC (OFIX) United States $0.708B 0.00
Mesa Laboratories (MLAB) United States $0.699B 16.49
IRadimed (IRMD) United States $0.699B 37.80
AxoGen (AXGN) United States $0.654B 0.00
Pacific Biosciences Of California (PACB) United States $0.622B 0.00
SiBone (SIBN) United States $0.580B 0.00
OrthoPediatrics (KIDS) United States $0.558B 0.00
Semler Scientific (SMLR) United States $0.535B 31.48
Treace Medical Concepts (TMCI) United States $0.488B 0.00
ClearPoint Neuro (CLPT) United States $0.453B 0.00
Tactile Systems Technology (TCMD) United States $0.440B 23.83
Delcath Systems (DCTH) United States $0.392B 0.00
AngioDynamics (ANGO) United States $0.370B 0.00
NeuroPace (NPCE) United States $0.331B 0.00
CVRx (CVRX) United States $0.330B 0.00
Inogen (INGN) United States $0.230B 0.00
Alpha Tau Medical (DRTS) Israel $0.215B 0.00
Accuray (ARAY) United States $0.204B 0.00
Sight Sciences (SGHT) United States $0.198B 0.00
KORU Medical Systems (KRMD) United States $0.177B 0.00
Nevro (NVRO) United States $0.162B 0.00
Atossa Genetics (ATOS) United States $0.153B 0.00
Sensus Healthcare (SRTS) United States $0.141B 15.12
Spectral Diagnostics (EDTXF) Canada $0.104B 0.00
Vicarious Surgical (RBOT) United States $0.094B 0.00
Monogram Orthopaedics (MGRM) United States $0.089B 0.00
LENSAR (LNSR) United States $0.089B 0.00
WORK Medical Technology Group (WOK) China $0.087B 0.00
InspireMD (NSPR) Israel $0.083B 0.00
EDAP TMS S.A (EDAP) France $0.082B 0.00
908 Devices (MASS) United States $0.079B 0.00
Hyperfine (HYPR) United States $0.073B 0.00
Covalon Technologies (CVALF) Canada $0.068B 0.00
EnVVeno Medical (NVNO) United States $0.051B 0.00
Lucid Diagnostics (LUCD) United States $0.045B 0.00
Envoy Medical (COCH) United States $0.045B 0.00
Rapid Micro Biosystems (RPID) United States $0.043B 0.00
Spectral AI (MDAI) United States $0.039B 0.00
Neuronetics (STIM) United States $0.036B 0.00
Adagio Medical Holdings (ADGM) United States $0.034B 0.00
Accelerate Diagnostics (AXDX) United States $0.033B 0.00
Precision Optics (POCI) United States $0.033B 0.00
NexGel (NXGL) United States $0.027B 0.00
DarioHealth (DRIO) United States $0.027B 0.00
Biosig Technologies (BSGM) United States $0.025B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.015B 0.00
Ekso Bionics Holdings (EKSO) United States $0.014B 0.00
Aspira Women's Health (AWH) United States $0.012B 0.00
Baird Medical Investment Holdings (BDMD) $0.011B 0.00
QT Imaging Holdings (QTI) United States $0.010B 0.00
T2 Biosystems (TTOO) United States $0.010B 0.00
PAVmed (PAVM) United States $0.009B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
Nuwellis (NUWE) United States $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Check-Cap (CHEK) Israel $0.004B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00